The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
The mucin MUC1 modulates the tumor immunological microenvironment through engagement of the lectin Siglec-9
Open accessAbstract
Siglec-9 is a sialic-acid-binding lectin expressed predominantly on myeloid cells. Aberrant glycosylation occurs in essentially all types of cancers and results in increased sialylation. Thus, when the mucin MUC1 is expressed on cancer cells, it is decorated by multiple short, sialylated O-linked glycans (MUC1-ST). Here we found that this cancer-specific MUC1 glycoform, through engagement of Siglec-9, ‘educated’ myeloid cells to release factors associated with determination of the tumor microenvironment and disease progression. Moreover, MUC1-ST induced macrophages to display a tumor-associated macrophage (TAM)-like phenotype, with increased expression of the checkpoint ligand PD-L1. Binding of MUC1-ST to Siglec-9 did not activate the phosphatases SHP-1 or SHP-2 but, unexpectedly, induced calcium flux that led to activation of the kinases MEK-ERK. This work defines a critical role for aberrantly glycosylated MUC1 and identifies an activating pathway that follows engagement of Siglec-9.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
Wanchoo, R., Karam, S., Uppal, N. N., Barta, V. S., Deray, G., Devoe, C., Launay-Vacher, V., Jhaveri, K. D., & on behalf of Cancer and Kidney International Network Workgroup on Immune Checkpoint Inhibitors (2017) · American Journal of Nephrology · doi:10.1159/000455014 · Cited by 15,256
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838
Microenvironmental regulation of tumor progression and metastasis
Quail, D. F., & Joyce, J. A. (2013) · Nature Medicine · doi:10.1038/nm.3394 · Cited by 7,994
Macrophage activation and polarization: nomenclature and experimental guidelines
Murray, P. J., Allen, J. E., Biswas, S. K., Fisher, E. A., Gilroy, D. W., Goerdt, S., Gordon, S., Hamilton, J. A., Ivashkiv, L. B., Lawrence, T., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.008 · Cited by 6,337
Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
Garon, E. B., Rizvi, N. A., Hui, R., Leighl, N., Balmanoukian, A. S., Eder, J. P., Patnaik, A., Aggarwal, C., Gubens, M., Horn, L., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1501824 · Cited by 6,198
Macrophage Diversity Enhances Tumor Progression and Metastasis
Qian, B.-Z., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,188
Tumor-Associated Macrophages: From Mechanisms to Therapy
Noy, R., & Pollard, J. W. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.010 · Cited by 4,089
Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma
Hamid, O., Robert, C., Daud, A., Hodi, F. S., Hwu, W.-J., Kefford, R., Wolchok, J. D., Hersey, P., Joseph, R. W., Weber, J. S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1305133 · Cited by 3,392
Glycosylation in cancer: mechanisms and clinical implications
Pinho, S. S., & Reis, C. A. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3982 · Cited by 3,083
CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
Qian, B.-Z., Li, J., Zhang, H., Kitamura, T., Zhang, J., Campion, L. R., Kaiser, E. A., Snyder, L. A., & Pollard, J. W. (2011) · Nature · doi:10.1038/nature10138 · Cited by 2,874
A synthetic inhibitor of the mitogen-activated protein kinase cascade.
Dudley, D. T., Pang, L., Decker, S. J., Bridges, A. J., & Saltiel, A. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.17.7686 · Cited by 2,679
Siglecs and their roles in the immune system
Crocker, P. R., Paulson, J. C., & Varki, A. (2007) · Nature Reviews Immunology · doi:10.1038/nri2056 · Cited by 2,031
Self-citationMYC regulates the antitumor immune response through CD47 and PD-L1
Casey, S. C., Tong, L., Li, Y., Do, R., Walz, S., Fitzgerald, K. N., Gouw, A. M., Baylot, V., Gütgemann, I., Eilers, M., et al. (2016) · Science · doi:10.1126/science.aac9935 · Cited by 1,403
Immune cell promotion of metastasis
Kitamura, T., Qian, B.-Z., & Pollard, J. W. (2015) · Nature Reviews Immunology · doi:10.1038/nri3789 · Cited by 1,158
Siglec-mediated regulation of immune cell function in disease
Macauley, M. S., Crocker, P. R., & Paulson, J. C. (2014) · Nature Reviews Immunology · doi:10.1038/nri3737 · Cited by 1,122
Self-citationMolecular cloning and expression of human tumor-associated polymorphic epithelial mucin.
Gendler, S. J., Lancaster, C. A., Taylor-Papadimitriou, J., Duhig, T., Peat, N., Burchell, J., Pemberton, L., Lalani, E. N., & Wilson, D. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)77254-2 · Cited by 976
Self-citationNitric oxide synthase in innate and adaptive immunity: an update
Bogdan, C. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.01.003 · Cited by 862
Kishihara, K., Penninger, J., Wallace, V. A., Kündig, T. M., Kawal, K., Wakeham, A., Timms, E., Pfeffer, K., Ohashi, P. S., Thomas, M. L., et al. (1993) · Cell · doi:10.1016/0092-8674(93)90302-7 · Cited by 490
Glycocalyx engineering reveals a Siglec-based mechanism for NK cell immunoevasion
Hudak, J. E., Canham, S. M., & Bertozzi, C. R. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1388 · Cited by 485
Jandus, C., Boligan, K. F., Chijioke, O., Liu, H., Dahlhaus, M., Démoulins, T., Schneider, C., Wehrli, M., Hunger, R. E., Baerlocher, G. M., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci65899 · Cited by 439
Human breast cancer cells educate macrophages toward the M2 activation status
Sousa, S., Brion, R., Lintunen, M., Kronqvist, P., Sandholm, J., Mönkkönen, J., Kellokumpu-Lehtinen, P.-L., Lauttia, S., Tynninen, O., Joensuu, H., et al. (2015) · Breast Cancer Research · doi:10.1186/s13058-015-0621-0 · Cited by 415
Carlin, A. F., Uchiyama, S., Chang, Y.-C., Lewis, A. L., Nizet, V., & Varki, A. (2009) · Blood · doi:10.1182/blood-2008-11-187302 · Cited by 401
Allavena, P., & Mantovani, A. (2012) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2011.04515.x · Cited by 384
Lloyd, K. O., Burchell, J., Kudryashov, V., Yin, B. W. T., & Taylor-Papadimitriou, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.52.33325 · Cited by 362
Self-citationMihara, M., Kasutani, K., Okazaki, M., Nakamura, A., Kawai, S., Sugimoto, M., Matsumoto, Y., & Ohsugi, Y. (2005) · International Immunopharmacology · doi:10.1016/j.intimp.2005.05.010 · Cited by 328
Priatel, J. J., Chui, D., Hiraoka, N., Simmons, C. J. T., Richardson, K. B., Page, D. M., Fukuda, M., Varki, N. M., & Marth, J. D. (2000) · Immunity · doi:10.1016/s1074-7613(00)80180-6 · Cited by 299
Hartnell, A., Steel, J., Turley, H., Jones, M., Jackson, D. G., & Crocker, P. R. (2001) · Blood · doi:10.1182/blood.v97.1.288 · Cited by 291
Self-citationRecent insights into the role of the PD-1/PD-L1 pathway in immunological tolerance and autoimmunity
Gianchecchi, E., Delfino, D. V., & Fierabracci, A. (2013) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.05.003 · Cited by 270
Plasminogen Activator Inhibitor-1 Regulates Tumor Growth and Angiogenesis
McMahon, G. A., Petitclerc, E., Stefansson, S., Smith, E., Wong, M. K. K., Westrick, R. J., Ginsburg, D., Brooks, P. C., & Lawrence, D. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105980200 · Cited by 263
Common variants in P2RY11 are associated with narcolepsy
Kornum, B. R., Kawashima, M., Faraco, J., Lin, L., Rico, T. J., Hesselson, S., Axtell, R. C., Kuipers, H., Weiner, K., Hamacher, A., et al. (2011) · Nature Genetics · doi:10.1038/ng.734 · Cited by 237
Zhang, J. Q., Nicoll, G., Jones, C., & Crocker, P. R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002788200 · Cited by 229
Self-citationLäubli, H., Pearce, O. M. T., Schwarz, F., Siddiqui, S. S., Deng, L., Stanczak, M. A., Deng, L., Verhagen, A., Secrest, P., Lusk, C., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1409580111 · Cited by 228
Environmental immune disruptors, inflammation and cancer risk
Thompson, P. A., Khatami, M., Baglole, C. J., Sun, J., Harris, S. A., Moon, E.-Y., Al-Mulla, F., Al-Temaimi, R., Brown, D. G., Colacci, A. M., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv038 · Cited by 227
O-Linked Glycosylation in the Mammary Gland: Changes that Occur During Malignancy
Burchell, J. M., Mungul, A., & Taylor-Papadimitriou, J. (2001) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1011331809881 · Cited by 221
Self-citationLolmede, K., Campana, L., Vezzoli, M., Bosurgi, L., Tonlorenzi, R., Clementi, E., Bianchi, M. E., Cossu, G., Manfredi, A. A., Brunelli, S., et al. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0908579 · Cited by 216
Identification of Siglec-9 as the receptor for MUC16 on human NK cells, B cells, and monocytes
Belisle, J. A., Horibata, S., Jennifer, G. A., Petrie, S., Kapur, A., André, S., Gabius, H.-J., Rancourt, C., Connor, J., Paulson, J. C., et al. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-118 · Cited by 207
Jutz, S., Leitner, J., Schmetterer, K., Doel-Perez, I., Majdic, O., Grabmeier-Pfistershammer, K., Paster, W., Huppa, J. B., & Steinberger, P. (2016) · Journal of Immunological Methods · doi:10.1016/j.jim.2016.01.007 · Cited by 207
Paul, S. P., Taylor, L. S., Stansbury, E. K., & McVicar, D. W. (2000) · Blood · doi:10.1182/blood.v96.2.483 · Cited by 204
Paul, S. P., Taylor, L. S., Stansbury, E. K., & McVicar, D. W. (2000) · Blood · doi:10.1182/blood.v96.2.483.014k40_483_490 · Cited by 202
Dalziel, M., Whitehouse, C., McFarlane, I., Brockhausen, I., Gschmeissner, S., Schwientek, T., Clausen, H., Burchell, J. M., & Taylor-Papadimitriou, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006523200 · Cited by 185
Self-citationAn 2,3 sialyltransferase (ST3Gal I) is elevated in primary breast carcinomas
Burchell, J., Poulsom, R., Hanby, A., Whitehouse, C., Cooper, L., Clausen, H., Miles, D., & Taylor-Papadimitriou, J. (1999) · Glycobiology · doi:10.1093/glycob/9.12.1307 · Cited by 180
Self-citationAvril, T., Floyd, H., Lopez, F., Vivier, E., & Crocker, P. R. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.11.6841 · Cited by 175
Self-citationSarrabayrouse, G., Bossard, C., Chauvin, J.-M., Jarry, A., Meurette, G., Quévrain, E., Bridonneau, C., Preisser, L., Asehnoune, K., Labarrière, N., et al. (2014) · PLoS Biology · doi:10.1371/journal.pbio.1001833 · Cited by 161
Luminal Lipid Regulates CD36 Levels and Downstream Signaling to Stimulate Chylomicron Synthesis
Tran, T. T. T., Poirier, H., Clément, L. C., Nassir, F., Pelsers, M. M. A. L., Petit, V., Degrace, P., Monnot, M.-C., Glatz, J. F. C., Abumrad, N. A., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.233551 · Cited by 151
Over-expression of ST3Gal-I promotes mammary tumorigenesis
Picco, G., Julien, S., Brockhausen, I., Beatson, R., Antonopoulos, A., Haslam, S. M., Mandel, U., Dell, A., Pinder, S. E., Taylor‐Papadimitriou, J., et al. (2010) · Glycobiology · doi:10.1093/glycob/cwq085 · Cited by 138
Self-citationPERUSSIA, B., Fanning, V., & Trinchieri, G. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.131.1.223 · Cited by 121
Beatson, R., Maurstad, G., Picco, G., Arulappu, A., Coleman, J., Wandell, H. H., Clausen, H., Mandel, U., Taylor‐Papadimitriou, J., Sletmoen, M., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125994 · Cited by 115
Self-citationBäckström, M., Thomas, L. I. N. K., Olson, F. J., Karlsson, H., Graham, R. A., Picco, G., Burchell, J., Taylor‐Papadimitriou, J., Noll, T., & Hansson, G. C. (2003) · Biochemical Journal · doi:10.1042/bj20031130 · Cited by 105
Self-citationRughetti, A., Pellicciotta, I., Biffoni, M., Bäckström, M., Link, T., Bennet, E. P., Clausen, H., Noll, T., Hansson, G. C., Burchell, J., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.12.7764 · Cited by 96
Self-citationAllen, M. D., Thomas, G. J., Clark, S. J., Dawoud, M. M., Vallath, S., Payne, S. J., Gomm, J. J., Dreger, S. A., Dickinson, S., Edwards, D. R., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1504 · Cited by 95
Ohta, M., Ishida, A., Toda, M., Akita, K., Inoue, M., Yamashita, K., Watanabe, M., Murata, T., Usui, T., & Nakada, H. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.10.079 · Cited by 94
Human Siglec-10 can bind to vascular adhesion protein-1 and serves as its substrate
Kivi, E., Elima, K., Aalto, K., Nymalm, Y., Auvinen, K., Koivunen, E., Otto, D. M. E., Crocker, P. R., Salminen, T. A., Salmi, M., et al. (2009) · Blood · doi:10.1182/blood-2009-04-219253 · Cited by 91
Self-citationTanida, S., Akita, K., Ishida, A., Mori, Y., Toda, M., Inoue, M., Ohta, M., Yashiro, M., Sawada, T., Hirakawa, K., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.471318 · Cited by 81
Xuan, Q., Wang, J., Nanding, A., Wang, Z., Liu, H., Lian, X., & Zhang, Q. (2014) · Pathology & Oncology Research · doi:10.1007/s12253-013-9740-z · Cited by 70
Oosterhoff, D., Lougheed, S. M., van de Ven, R., Lindenberg, J. J., van Cruijsen, H., Hiddingh, L., Kroon, J., van den Eertwegh, A. J. M., Hangalapura, B. N., Scheper, R. J., et al. (2012) · OncoImmunology · doi:10.4161/onci.20365 · Cited by 66
Engagement of Siglec-7 Receptor Induces a Pro-Inflammatory Response Selectively in Monocytes
Varchetta, S., Brunetta, E., Roberto, A., Mikulak, J., Hudspeth, K. L., Mondelli, M. U., & Mavilio, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045821 · Cited by 61
Bauerle, K. T., Schweppe, R. E., Lund, G. S., Kotnis, G. R., Deep, G., Agarwal, R., Pozdeyev, N. V., Wood, W. M., & Haugen, B. R. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3636 · Cited by 58
CD33 Detection by Immunohistochemistry in Paraffin-Embedded Tissues
Hoyer, J. D., Grogg, K. L., Hanson, C. A., Gamez, J. D., & Doǧan, A. (2008) · American Journal of Clinical Pathology · doi:10.1309/e36008y2h08q1ayy · Cited by 54
Discoidin Domain Receptor 1 Protein Is a Novel Modulator of Megakaryocyte-Collagen Interactions
Abbonante, V., Gruppi, C., Rubel, D., Groß, O., Moratti, R., & Balduini, A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.431528 · Cited by 52
Chang, T., Poltoratsky, V. P., & Vancurova, I. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402610 · Cited by 51
Ishida, A., Akita, K., Mori, Y., Tanida, S., Toda, M., Inoue, M., & Nakada, H. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.523480 · Cited by 50
Hengartner, N.-E., Fiedler, J., Schrezenmeier, H., Huber-Lang, M. S., & Brenner, R. E. (2015) · PLoS ONE · doi:10.1371/journal.pone.0116772 · Cited by 48
CD95 co-stimulation blocks activation of naive T cells by inhibiting T cell receptor signaling
Strauß, G., Lindquist, J. A., Arhel, N. J., Felder, E., Karl, S., Haas, T. L., Fulda, S., Walczak, H., Kirchhoff, F., & Debatin, K. (2009) · The Journal of Experimental Medicine · doi:10.1084/jem.20082363 · Cited by 48
Chen, H., Peng, H., Liu, W., et al. (2015) · Surgery · doi:10.1016/j.surg.2015.04.053 · Cited by 48
Angelucci, C., Maulucci, G., Colabianchi, A. M. C., Iacopino, F., D’Alessio, A., Maiorana, A., Palmieri, V., Papi, M., Spirito, M. D., Leone, A. D., et al. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.135 · Cited by 47
Julien, S., Grimshaw, M. J., Sutton‐Smith, M., Coleman, J., Morris, H. R., Dell, A., Taylor‐Papadimitriou, J., & Burchell, J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.9.5701 · Cited by 46
Self-citationForouzandeh, F., Jalili, R. B., Germain, M., Duronio, V., & Ghahary, A. (2007) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-007-9635-y · Cited by 46
Thapa, B., Koo, B.-S., Kim, Y. H., Kwon, H., & Kim, D. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.07.070 · Cited by 39
CD14+HLA-DRlow/− expression: A novel prognostic factor in chronic lymphocytic leukemia
Liu, J., Zhou, Y., Huang, Q., & Qiu, L. (2014) · Oncology Letters · doi:10.3892/ol.2014.2808 · Cited by 39
Modulation of Human Immune Responses by Bovine Interleukin-10
den Hartog, G., Savelkoul, H. F. J., Schoemaker, R., Tijhaar, E. J., Westphal, A. H., Ruiter, T. E.-D., Schrijver, E. H. R., & van Neerven, R. J. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018188 · Cited by 35
CDDO-Me Redirects Activation of Breast Tumor Associated Macrophages
Ball, M. S., Shipman, E. P., Kim, H. J., Liby, K. T., & Pioli, P. A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149600 · Cited by 34
The functional contribution of calcium ion flux heterogeneity in T cells
Christo, S. N., Diener, K. R., & Hayball, J. D. (2015) · Immunology and Cell Biology · doi:10.1038/icb.2015.34 · Cited by 30
Lysophosphatidic acid enhances survival of human CD34+ cells in ischemic conditions
Kostić, I., Fidalgo-Carvalho, I., Aday, S., Vazão, H., Carvalheiro, T., Grãos, M., Duarte, A., Cardoso, C. M. P., Gonçalves, L. M. M., Carvalho, L., et al. (2015) · Scientific Reports · doi:10.1038/srep16406 · Cited by 26
Zou, Y., Bao, J., Pan, X., Lü, Y., Sihong, L., Wang, X., Wang, G., & Lin, D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134568 · Cited by 19
T-cell-biased immune responses generated by a mucosally targeted adenovirus-σ1 vaccine
Weaver, E. A., Mercier, G. T., Gottschalk, S. M., & Barry, M. A. (2012) · Mucosal Immunology · doi:10.1038/mi.2012.11 · Cited by 10
Cited by
Tumor-Associated Macrophages in Tumor Immunity
Pan, Y., Yu, Y., Wang, X., & Zhang, T. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.583084 · Cited by 1,872
Harnessing innate immunity in cancer therapy
Demaria, O., Cornen, S., Daëron, M., Morel, Y., Medzhitov, R., & Vivier, E. (2019) · Nature · doi:10.1038/s41586-019-1593-5 · Cited by 957
Chen, F., Chen, J., Yang, L., Liu, J., Zhang, X., Zhang, Y., Tu, Q., Yin, D., Lin, D., Wong, P.-P., et al. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0299-0 · Cited by 712
Glycosylation in the Era of Cancer-Targeted Therapy: Where Are We Heading?
Mereiter, S., Balmaña, M., Campos, D., Gomes, J., & Reis, C. A. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.06.006 · Cited by 565
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
Smith, B. A. H., & Bertozzi, C. R. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-00093-1 · Cited by 500
Metadata
- Authors
- Beatson, R., Tajadura-Ortega, V., Achkova, D., Picco, G., Tsourouktsoglou, T.-D., Klausing, S., Hillier, M., Maher, J., Noll, T., Crocker, P. R., Taylor-Papadimitriou, J., & Burchell, J. M.
- Venue
- Nature Immunology
- Published
- 2016-09-05
- Volume
- 17
- Issue
- 11
- Pages
- 1273-1281
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- OpenAlex
- W2516359951
- Cited by
- 378
- References
- 76
- FWCI
- 9.93
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.